Navigation Links
Pitt discovery holds potential in destroying drug-resistant bacteria
Date:5/7/2013

Through the serendipity of science, researchers at the University of Pittsburgh have discovered a potential treatment for deadly, drug-resistant bacterial infections that uses the same approach that HIV uses to infect cells.

The National Institutes of Health-supported discovery will be described in the June issue of the journal Antimicrobial Agents and Chemotherapy. It is especially promising in the development of a potential treatment for lung infections in people with cystic fibrosis.

"The discovery of this new antibiotic was an unexpected result of basic research on HIV proteins," said senior author Ronald Montelaro, Ph.D., professor and co-director of Pitt's Center for Vaccine Research (CVR). "As a result of studying these proteins, we discovered novel structures that turn out to work very well against bacterial infections, including the complicated bacterial populations in lung infections in cystic fibrosis patients."

Cystic fibrosis is a genetic disorder that leads to thick, viscous secretions in the lungs and other organs in about 30,000 children and adults in the United States, according to the Cystic Fibrosis Foundation. Lung infections resistant to antibiotics often are deadly for people with cystic fibrosis. About 80 percent of cystic fibrosis patients have at least one antibiotic-resistant infection in their lungs by age 18.

"Infections with progressively resistant bacteria in the lung shorten the lives of people with cystic fibrosis," said Joseph M. Pilewski, M.D., co-director of the Adult Cystic Fibrosis Center at UPMC. "What happens is the genetic defect predisposes patients to infections that drive the production of mucus that then blocks the airways and makes it difficult to breath."

Dr. Montelaro and his colleagues found that a particular sequence of amino acids on the tail end of HIV allow the virus to "punch into" and infect cells. The team manufactured a synthetic and more efficie
'/>"/>

Contact: Allison Hydzik & Cyndy McGrath
hydzikam@upmc.edu
412-647-9975
University of Pittsburgh Schools of the Health Sciences
Source:Eurekalert

Page: 1 2 3

Related biology news :

1. Discovery of new hormone opens doors to new type 2 diabetes treatments
2. Discovery may help prevent chemotherapy-induced anemia
3. Discovery may help prevent HIV reservoirs from forming
4. An important discovery in breast cancer by IRCM researchers
5. Genetic discovery found to influence obesity in people of African ancestry
6. Accidental discovery may lead to improved polymers
7. Gene discovery may yield lettuce that will sprout in hot weather
8. UGA discovery may allow scientists to make fuel from CO2 in the atmosphere
9. Discovery could increase efficacy of promising cystic fibrosis drug
10. Discovery of first motor with revolution motion in a virus-killing bacteria advances nanotechnology
11. Discovery could yield treatment for cocaine addicts
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/24/2015)... 2015 This report provides market analysis of ... years. It contains an analysis of the drivers, challenges, ... impact from the short, medium, and long term perspective ... market, and technology trends that currently, prevail in the ... authorities to efficiently manage the increasing marine traffic and ...
(Date:6/24/2015)... 24, 2015 Biometry authentication provider KeyLemon ... password solution one face in. ... one face in, entering the expanding biometric authentication ... multifactor-authentication biometric answer to the password problem. With ... partnership with KeyLemon, one face in allows users ...
(Date:6/23/2015)... , June 23, 2015   Valencell, ... announced the results of a recent study that ... on the wrist during activity. In a study ... was compared along with the Apple Watch against ... measuring heart rate during activity. The study demonstrated ...
Breaking Biology News(10 mins):Automatic Identification System Market by Class, by Platform, by Application and by Geography - Global Forecasts & Analysis to 2014 - 2020 2KeyLemon Announces Partnership With Biometric Password Solution onefacein 2Valencell Delivers Breakthrough Heart Rate Accuracy on the Wrist 2Valencell Delivers Breakthrough Heart Rate Accuracy on the Wrist 3
... method for identifying Bacillus anthracis, the causative agent of ... U.S. Food and Drug Administration (FDA). The test, known ... at the U.S. Army Medical Research Institute of Infectious ... used with clinical specimens. The original form of the ...
... today been announced in Yemen, bringing the reported total number ... had been polio-free since disease surveillance began in 1996 - ... of the outbreak. Experts fear that the number of cases ... and Ministry of Health epidemiologists and paediatricians remain on the ...
... discovered that GCN2, a protein in cells that inhibits ... be a master regulator of the switch from short-term ... synaptic plasticity and memory by the eIF2a kinase GCN2, ... the journal Nature, provides the first genetic evidence that ...
Cached Biology News:Anthrax test, developed by army and CDC, receives FDA approval 2Anthrax test, developed by army and CDC, receives FDA approval 3New Vaccine To Be Used For First Time In Polio Outbreak Response 2Montreal researchers probe the genetic basis of memory 2
(Date:7/3/2015)... Houston, Texas (PRWEB) , ... July 03, 2015 ... ... search firm, highly-regarded by Fortune 500 companies and professional service industries alike-- typically ... aimed to make clients laugh, honor a good cause and break from their ...
(Date:7/3/2015)... July 3, 2015 ... Open Innovation in Science", som finner sted ... sendes på nett, på  http://www.openinnovationinscience.at , og ... De to største utfordringene innen ... undersøke nye forskningsspørsmål og kompleksiteten av nåværende ...
(Date:7/2/2015)... ... 03, 2015 , ... Cuvettes have been used in countless labs for decades. In the ... they needed. As expected, this was a daunting and tiring process looking at endless ... were not able to navigate the complex catalog structure. , Now thanks to FireflySci, scientists ...
(Date:7/2/2015)... -- Amici Procurement Migrates to the Cloud ... has chosen Microsoft Cloud Solution Provider iomart ...      (Logo: http://photos.prnewswire.com/prnh/20121126/579634) , ... the bio-tech sector with a unique procurement service, helping ... help them obtain best value. Its IT platform hosts ...
Breaking Biology Technology:The Alexander Group Declares Their Independence with a Bit of Levity 2Lansering av verdens første Open Innovation-program for utdanning av forskere 2Lansering av verdens første Open Innovation-program for utdanning av forskere 3New Cuvette E-Commerce Website Launched by FireflySci 2Biotech Procurement Company Moves to Office 365 with iomart 2
... Animals and humans no longer need to be "sitting ... outbreaks. Rather than being caught off-guard by mass influenza ... the concentration and structure of the genomic Replikins in ... year or longer, which provides advance warning of, and ...
... engines, which transform chemical, thermal or electrical energy into kinetic ... B. Nature does the same thing; in cells, so-called motor ... carry out this task. Usually they glide along other ... process "burn" ATP (adenosine triphosphate), the chemical fuel, so to ...
... HealthCare,s affiliate MEDRAD, Inc. today announced that five-year ... percent relative reduction in target lesion revascularization (TLR) ... arterial disease (PAD) treated with the Cotavance® drug ... balloon angioplasty (POBA). Additionally, for patients requiring TLR, ...
Cached Biology Technology:"Sitting Ducks" No Longer: Advance Flu Warning Permits Creation of Replikins Custom Synthetic Flu Vaccine in Animals 2"Sitting Ducks" No Longer: Advance Flu Warning Permits Creation of Replikins Custom Synthetic Flu Vaccine in Animals 3"Sitting Ducks" No Longer: Advance Flu Warning Permits Creation of Replikins Custom Synthetic Flu Vaccine in Animals 4A nano car with molecular 4-wheel drive 2A nano car with molecular 4-wheel drive 3Bayer HealthCare's Cotavance® Drug Eluting Balloon With Paccocath® Technology Reduced Five-Year Target Lesion Revascularization Rates by 59 Percent in PAD Patients Compared to Those Treated With Uncoated Balloon 2Bayer HealthCare's Cotavance® Drug Eluting Balloon With Paccocath® Technology Reduced Five-Year Target Lesion Revascularization Rates by 59 Percent in PAD Patients Compared to Those Treated With Uncoated Balloon 3Bayer HealthCare's Cotavance® Drug Eluting Balloon With Paccocath® Technology Reduced Five-Year Target Lesion Revascularization Rates by 59 Percent in PAD Patients Compared to Those Treated With Uncoated Balloon 4
... Buffer I can be used in intracellular ... permeabilize cells and to serve as an ... saponin-mediated cell permeabilization is a reversible process, ... in the presence of saponin during intracellular ...
Mouse monoclonal antibody raised against a full length recombinant GPT. NCBI Entrez Gene ID = GPT...
Mouse monoclonal antibody raised against a partial recombinant TPR. NCBI Entrez Gene ID = TPR...
... kit contains sufficient materials for 1,464 array sample elements. ... 4 each , Blocker BSA in PBS (10X): 50 ... Phosphate Buffered Saline: 8 packs , 10% Tween-20: 2 ... Enhancer: 2 x 25 ml , SuperSignal West Pico ...
Biology Products: